INITIAL, CLINICAL-TRIAL OF A NEW, SPECIFIC 5-HT REUPTAKE INHIBITOR, CITALOPRAM (LU 10-171)

被引：47

作者：

GOTTLIEB, P ^{[1
]}

WANDALL, T ^{[1
]}

OVERO, KF ^{[1
]}

机构：

[1] H LUNDBECK & CO AS,RES LABS,DK-2500 COPENHAGEN,DENMARK

来源：

ACTA PSYCHIATRICA SCANDINAVICA | 1980年 / 62卷 / 03期

关键词：

D O I：

10.1111/j.1600-0447.1980.tb00611.x

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

收藏

页码：236 / 344

页数：109

相关论文

共 11 条

[1] TREATMENT OF DEPRESSION WITH TRICYCLIC DRUGS - PHARMACOKINETIC AND PHARMACODYNAMIC ASPECTS
ASBERG, M
[J]. PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE, 1976, 9 (01): : 18 - 26
[2] Carlsson A., 1966, MECHANISMS RELEASE B, P331
[3] PHARMACOLOGY OF A NEW PHTHALANE (LU 10-171), WITH SPECIFIC 5-HT UPTAKE INHIBITING PROPERTIES
CHRISTENSEN, AV
FJALLAND, B
PEDERSEN, V
DANNESKIOLDSAMSOE, P
SVENDSEN, O
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 41 (02) : 153 - 162
[4] FREDRICSONOVERO K, 1978, EUR J CLIN PHARMACOL, V14, P69
[5] A RATING SCALE FOR DEPRESSION
HAMILTON, M
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) : 56 - 62
[6] HOPFNERPETERSEN HE, 1978, NORD PSYKIAT T, V32, P463
[7] HYTTEL J, 1977, ACTA PHARMACOL TOX, V40, P439
[8] EFFECT OF A SPECIFIC 5-HT UPTAKE INHIBITOR, CITALOPRAM (LU 10-171), ON H-3-5-HT UPTAKE IN RAT-BRAIN SYNAPTOSOMES INVITRO
HYTTEL, J
[J]. PSYCHOPHARMACOLOGY, 1978, 60 (01) : 13 - 18
[9] NEUROCHEMICAL CHARACTERIZATION OF A NEW POTENT AND SELECTIVE SEROTONIN UPTAKE INHIBITOR - LU-10-171
HYTTEL, J
[J]. PSYCHOPHARMACOLOGY, 1977, 51 (03) : 225 - 233
[10] LINGJAERDE O, 1977, NORD PSYKIAT T, V31, P384